Atrium Therapeutics, Inc.

NASDAQ:RNA

Biotechnology

Healthcare
$6.64 +1.28%

+$0.16 today

Market cap
$143.23M
Beta
0.42
P/E (TTM)
-3.3
EPS (TTM)
-$3.78
52W Low $11.40High $16.77

Volume 0.22M

Average 0.35M

RNA Weighted Avg Shares

Average number of basic shares outstanding during the period, used to calculate basic EPS.

Atrium Therapeutics, Inc.NASDAQ: RNA

Weighted Avg Shares · Q1 FY2026 · quarter ended Mar 2026

Weighted avg shares of 17.11M shares in Q1 FY2026

Q1 FY2026 weighted avg shares was 17.11M shares.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterMar 2026
17.11M-0.1% QoQ
Last fiscal yearDec 2025
17.11M— YoY
Weighted Avg Shares past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Weighted Avg Shares history

Shares · from the income statement

Latest · FY2025
17.11M USD
Year-over-year change
—

Weighted Avg Shares vs competitors

How RNA compares with its peers on the latest reported figures

No competitor Weighted Avg Shares figures are available to compare.

Atrium Therapeutics, Inc.

NASDAQ:RNA

Intrinsic Alpha fair value

Locked

Current Price

$6.64

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.